Physician profile
Susan E Price
NPI 1275773574
$1,262.03
in general payments reported to CMS, 2019-2025
19 companies · $336 in 2025
The $336 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $283 · 2022: $142 · 2023: $262 · 2024: $239 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $827 · Travel and Lodging: $10.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $827.21 |
| Travel and Lodging | $10.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $191.79 | 2023-2025 | Ingrezza |
| Biogen, INC. | $150.00 | 2021 | |
| Boston Scientific Corporation | $142.03 | 2021-2025 | General - Dbs |
| Teva Pharmaceuticals USA, INC. | $141.20 | 2024 | Austedo Xr |
| Tg Therapeutics, INC. | $140.27 | 2025 | |
| Medtronic, INC. | $55.66 | 2021-2023 | Activa PC |
| Abbott Laboratories | $53.25 | 2024 | Infinity |
| Abbvie INC. | $50.86 | 2022-2024 | |
| Avion Pharmaceuticals | $50.04 | 2022 | |
| Kyowa Kirin, INC. | $38.80 | 2021 | |
| Dexcom, INC. | $35.07 | 2025 | Dexcom G6 Transmitter |
| Acadia Pharmaceuticals INC | $35.00 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $33.28 | 2025 | |
| Acorda Therapeutics, INC | $28.75 | 2022 | |
| Alexion Pharmaceuticals, INC. | $26.51 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $25.76 | 2025 | |
| Sunovion Pharmaceuticals INC. | $23.52 | 2021 | |
| Ge Healthcare | $21.78 | 2023 | |
| Amneal Pharmaceuticals LLC | $18.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Price listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.